0001104659-24-088925.txt : 20240813 0001104659-24-088925.hdr.sgml : 20240813 20240813160110 ACCESSION NUMBER: 0001104659-24-088925 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240811 FILED AS OF DATE: 20240813 DATE AS OF CHANGE: 20240813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kim Hyung Heon CENTRAL INDEX KEY: 0001873258 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 241201211 MAIL ADDRESS: STREET 1: C/O DONG-A ST & DONG-A SOCIO GROUP STREET 2: 64 CHEONHO DAERO, DONGDAEMUN-GU CITY: SEOUL STATE: M5 ZIP: 00000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001638287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472389984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 545 CONCORD AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: (857) 702-9600 MAIL ADDRESS: STREET 1: 545 CONCORD AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 FORMER COMPANY: FORMER CONFORMED NAME: Gemphire Therapeutics Inc. DATE OF NAME CHANGE: 20150331 4 1 tm2421534-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-08-11 0 0001638287 NeuroBo Pharmaceuticals, Inc. NRBO 0001873258 Kim Hyung Heon C/O NEUROBO PHARMACEUTICALS, INC. 545 CONCORD AVENUE, SUITE 210 CAMBRIDGE MA 02138 1 1 0 0 CEO & President 0 Common Stock 2024-08-11 4 F 0 11467 3.60 D 66666 D Shares were withheld by the Issuer in satisfaction of the Reporting Person's tax liabilities in connection with the vesting of restricted stock units, based on the Issuer's closing price on August 9, 2024. The total number of securities beneficially owned has been adjusted to reflect the Issuer's completion of a 1-for-8 reverse stock split on December 20, 2023. /s/ Phillip D. Torrence, by Power of Attorney 2024-08-13